Shanghai Chest Hospital
Clinical trials sponsored by Shanghai Chest Hospital, explained in plain language.
-
New combo attack on tough esophageal cancer
Disease control OngoingThis study is testing a three-part treatment for people with advanced esophageal cancer who cannot have surgery. First, patients receive immunotherapy plus chemotherapy, followed by a combination of chemotherapy and radiation. The goal is to see if this approach helps control the…
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Three-Drug attack on Tough-to-Treat lung cancer
Disease control OngoingThis study is testing whether a three-drug combination can help control advanced lung cancer that has a specific genetic change called an EGFR exon 20 insertion. It will involve about 54 adults with this type of non-squamous non-small cell lung cancer who haven't had prior treatm…
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Targeted attack on rare lung cancer mutations
Disease control OngoingThis study is testing a drug called dacomitinib for people with advanced non-small cell lung cancer who have specific, less common genetic mutations in their tumors. It aims to see how well the drug controls the cancer and how safe it is. About 30 participants will take the oral …
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC